Brokerages Set Addus HomeCare Corporation (NASDAQ:ADUS) Target Price at $131.00

Addus HomeCare Corporation (NASDAQ:ADUS) has earned a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $131.00.

ADUS has been the subject of several research reports. Weiss Ratings cut Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 22nd. Wall Street Zen lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. Barclays dropped their target price on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. Finally, Citizens Jmp reiterated a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th.

Addus HomeCare Trading Up 0.2%

Shares of Addus HomeCare stock opened at $105.97 on Friday. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. Addus HomeCare has a twelve month low of $87.95 and a twelve month high of $124.43. The firm has a market capitalization of $1.98 billion, a PE ratio of 19.59, a P/E/G ratio of 1.45 and a beta of 0.88. The firm’s 50-day moving average price is $95.53 and its 200 day moving average price is $101.11.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. The business had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The business’s revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.42 earnings per share. On average, sell-side analysts predict that Addus HomeCare will post 6.24 EPS for the current fiscal year.

Insider Transactions at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the transaction, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. The trade was a 0.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 966 shares of company stock worth $90,168. 4.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors have recently added to or reduced their stakes in the stock. Leeward Investments LLC MA increased its stake in shares of Addus HomeCare by 9.4% in the 1st quarter. Leeward Investments LLC MA now owns 120,857 shares of the company’s stock worth $11,318,000 after acquiring an additional 10,414 shares during the last quarter. Burney Co. acquired a new position in shares of Addus HomeCare during the 4th quarter valued at about $1,841,000. Capital Research Global Investors grew its holdings in shares of Addus HomeCare by 9.0% in the third quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock valued at $141,772,000 after purchasing an additional 99,262 shares during the period. Vanguard Group Inc. increased its position in Addus HomeCare by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock worth $140,531,000 after purchasing an additional 10,501 shares during the last quarter. Finally, 8 Knots Management LLC acquired a new stake in Addus HomeCare during the third quarter worth about $6,075,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.